New sickle cell drug shows promise in early safety trial
Disease control
Completed
This early-stage study tested a new drug, Pociredir (FTX-6058), in 45 adults with sickle cell disease to see if it is safe and how the body processes it. The main goal was to check for side effects and measure drug levels in the blood. Researchers also looked at changes in fetal …
Phase: PHASE1 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC